You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis C Genotype 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)

Completed
Has Results
  • Chronic Hepatitis C Genotype 1
  • (no location specified)
Jan 15, 2021

Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

Active, not recruiting
  • Hepatitis C Virus (HCV)
    • Chelyabinsk, Russian Federation
    • +9 more
    Mar 1, 2022

    Zepatier in Patients With Substance Use

    Active, not recruiting
    • Hepatitis C
    • +3 more
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Chicago, Illinois
      University of Illinois at Chicago
    Jun 28, 2022

    Hepatitis C Trial in Seoul

    Completed
    • Hepatitis C
      • Seoul, Korea, Republic of
        Local Institution
      Jan 6, 2022

      Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

      Completed
      Has Results
      • Chronic Hepatitis C
      • Baltimore, Maryland
        Institute of Human Virology University of Maryland
      Apr 26, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

      Completed
      Has Results
      • Hepatitis C Infection
      • Hepatitis C Virus
      • (no location specified)
      Jul 28, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • Compensated Cirrhosis
      • (no location specified)
      Jul 8, 2021

      Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +3 more
      • ABT-493 coformulated with ABT-530
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • ABT-450/r/ABT-267, ABT-333
      • +2 more
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • ABT-450/r/ABT-267, ABT-333
      • +2 more
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • Compensated Cirrhosis
      • ABT-450/r/ABT-267, ABT-333
      • Ribavirin (RBV)
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 8, 2021

      Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

      Completed
      • Hepatitis C, Chronic
      • PEGASYS 180 µg Q1W
      • +3 more
      • Changhua, Taiwan
      • +12 more
      Oct 7, 2021

      Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

      Terminated
      Has Results
      • Hepatitis C
      • Simeprivir (SMV)
      • +2 more
      • Denver, Colorado
        University of Colorado Denver (Leprino Building)
      Aug 16, 2021

      Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

      Completed
      Has Results
      • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
      • Phoenix, Arizona
      • +47 more
      Jun 27, 2022

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • ABT-450/r/ABT-267, ABT-333
      • +4 more
      • (no location specified)
      Jul 29, 2021

      Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

      Completed
      Has Results
      • Hepatitis C Infection
      • (no location specified)
      Jan 15, 2021

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • ABT-450/r/ABT-267, ABT-333
      • +4 more
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

      Recruiting
      • Chronic Hepatitis C
      • Chronic Hepatitis B
      • Tenofovir Alafenamide 25 MG
      • Sofosbuvir / Velpatasvir
      • Beijing, Beijing, China
        Peking University First Hospital
      Aug 2, 2021

      Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +3 more
      • (no location specified)
      Jul 8, 2021